Skip to main content
CSPC Pharmaceutical Group Limited logo

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,523 across all filing types
Latest filing 2021-03-16 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - DUAL INHIBITOR JAK-SyK "SYHX1901" OBTAINS CLINICAL TRIAL APPROVAL
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by CSPC Pharmaceutical Group Limited regarding the clinical trial approval of a new product, SYHX1901. It is not a financial report, earnings release, or any form of regulatory filing related to financial performance or governance. The document is short (2600 characters) and serves as an announcement of a significant development related to the company's product pipeline. It does not contain financial data, management discussion, or shareholder voting information. It is not related to capital changes, mergers, or legal proceedings. Therefore, the most appropriate classification is a Regulatory Filing (RNS), which serves as a general category for miscellaneous announcements that do not fit other specific categories.
2021-03-16 English
ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020
Annual Report Classification · 100% confidence The document is titled 'ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020' and contains detailed financial highlights, chairman's statement, business review, outlook, and a consolidated statement of profit or loss for the full fiscal year 2020. It includes comprehensive financial data, management discussion, and analysis of business performance over the year. The length of the document (15,000 characters) and the presence of full financial statements and detailed narrative confirm it is a full annual report rather than a brief announcement or a regulatory filing. Therefore, the document fits the definition of an Annual Report (10-K). FY 2020
2021-03-15 English
VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AND COMMERCIALIZATION AGREEMENT
Capital/Financing Update Classification · 95% confidence The document is a voluntary announcement by CSPC Pharmaceutical Group Limited regarding a product licensing and commercialization agreement. It details the terms of the agreement, including payments and rights related to a pharmaceutical product. There is no indication that this is a full financial report, audit, earnings release, or regulatory filing. The document is relatively short (3789 characters) and serves as an announcement of a business agreement rather than a detailed report or financial statement. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a regulatory compliance filing or certification. The content is about a licensing agreement, which is a form of capital or financing update related to business operations and agreements. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-03-10 English
VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AND COMMERCIALIZATION AGREEMENT
Capital/Financing Update Classification · 95% confidence The document is a voluntary announcement by CSPC Pharmaceutical Group Limited regarding a product licensing and commercialization agreement with Beta Pharma. It details the terms of the agreement, including exclusive rights and share subscription, but does not contain financial statements or detailed financial performance data. The document is relatively short (2875 characters) and serves as an update on a business transaction rather than a full financial report or regulatory filing. It is not an annual or interim report, earnings release, or management discussion. It is also not a regulatory certification or voting result announcement. The content fits best under Capital/Financing Update (CAP) as it involves subscription of shares and a licensing agreement impacting the company's capital and business operations.
2021-03-09 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors and their roles, including committee memberships. It is an announcement related to the company's board structure and management composition. There is no financial data, no report or presentation content, and no mention of voting results or other meeting materials. This fits the category of Board/Management Information (MANG). The document length is short and focused solely on board composition, confirming it is not a full report or other filing type.
2021-03-09 English
APPOINTMENT AND RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTORS
Board/Management Information Classification · 100% confidence The document is an announcement from CSPC Pharmaceutical Group Limited regarding the appointment and resignation of independent non-executive directors. It details the biographical information of the newly appointed director and confirms the resignation of another director. There is no financial data, no discussion of financial results, no mention of shareholder voting results, or any other report type. The content clearly fits the category of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2021-03-05 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.